Hormone Pulsatility: Why Your Body Doesn't Use Steady-State

Why pulsatility exists

Continuous hormone exposure tends to downregulate receptors. Pulsatile release prevents desensitization, allowing sustained signaling without receptor exhaustion. The body has evolved this pattern across multiple endocrine systems.

Pulsatile patterns

• GnRH, 60-120 min pulses
• LH, follows GnRH
• Testosterone, bursts during REM sleep
• Growth hormone, 4-5 pulses overnight, mostly during deep sleep
• Cortisol, multiple pulses through day with strong diurnal envelope
• Insulin, pulsatile from beta cells
• Thyroid (TSH), modest pulsatility

Information encoding

Pulse parameters encode different signals:

• Frequency, slow GnRH pulses favor FSH; fast pulses favor LH
• Amplitude, pulse height affects total signal magnitude
• Pattern, diurnal vs random vs triggered all carry meaning

Receptor effects

Receptor responses differ:

• Pulsatile exposure maintains receptor expression and responsiveness
• Continuous exposure leads to receptor downregulation and tachyphylaxis
• The same total dose can produce very different outcomes depending on delivery pattern

TRT implications

For testosterone replacement:

• Weekly IM injection: large peak then trough, non-physiologic
• Twice-weekly injection: smaller peaks, less variation
• Daily small subq dose: closer to physiologic stable level
• Patients on more frequent dosing often report more stable mood, energy, and fewer side effects

Other implications

• GnRH agonists (continuous, not pulsatile) cause receptor downregulation, used for prostate cancer T suppression
• Growth hormone replacement at bedtime mimics natural pulse timing
• Thyroid replacement at consistent time supports physiologic rhythm

Bottom line

Most hormones are pulsatile. Pulsatility carries information and prevents receptor desensitization. For replacement therapy, mimicking physiologic pulses or smoothing delivery often produces better outcomes than infrequent large doses.